Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)Published
Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study
16 of 35 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- European journal of cancer (Oxford, England : 1990)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Acrylamides; Aniline Compounds; Morpholines; Pyrimidines; Indoles; Quinazolines; Antineoplastic Combined Chemotherapy Protocols; Protein Kinase Inhibitors; Treatment Outcome
- PubMed ID
- 40730077
- Added to directory
- Source checked